Increasing F2-isoprostanes in the first month after birth predicts poor respiratory and neurodevelopmental outcomes in very preterm infants.
about
Increasing F2-isoprostanes in the first month after birth predicts poor respiratory and neurodevelopmental outcomes in very preterm infants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increasing F2-isoprostanes in ...... comes in very preterm infants.
@en
Increasing F2-isoprostanes in ...... comes in very preterm infants.
@nl
type
label
Increasing F2-isoprostanes in ...... comes in very preterm infants.
@en
Increasing F2-isoprostanes in ...... comes in very preterm infants.
@nl
prefLabel
Increasing F2-isoprostanes in ...... comes in very preterm infants.
@en
Increasing F2-isoprostanes in ...... comes in very preterm infants.
@nl
P2093
P2860
P50
P356
P1476
Increasing F2-isoprostanes in ...... comes in very preterm infants.
@en
P2093
J L Aschner
M A Matthews
P2860
P2888
P304
P356
10.1038/JP.2016.74
P577
2016-05-12T00:00:00Z